Product


ColonSeq: Colon Cancer genetic test
Colon cancer affects average 6% of the population.
Lynch syndrome and familial adenomatous polyposis are the most common Colon cancer syndromes. The massive sequencing or Next-generation Sequencing offers the possibility of analyzing 15 genes associated with different syndromes of hereditary colon cancer simultaneously. Some of these genes increase also the risk of developing other cancers such as breast, ovarian or pancreatic cancer.
 
Cancer is one of the leading causes of death by disease in the world. Approximately 5% to 10% of all cancers are hereditary origin. This means that changes (or mutations) in specific genes responsible for the disease are transmitted from parents to children. People who carry in their DNA such changes are more likely to develop cancer during their lifetime.
The latest knowledge and technology allows us to analyze the DNA of multiple genes related to hereditary cancer.
The HC-Gen Test is the ideal tool to identify genetic variations related to cancer in your patients. It is a genetic test that allows the simultaneous detection of mutations in ALL the genes associated with hereditary cancer syndromes using ultrasequencing DNA techniques.
 
 
Related links:
 
 
Permalink  
 
Developed by Web4Bio